Search or Ask Iris
Ctrl+K
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Phytochem Remedies (India) Limited, incorporated in 2002, is a manufacturer of high-quality corrugated packaging solutions. The company specializes in producing printed boxes, rolls, pads, and sheets, catering to diverse industries such as pharmaceuticals, agriculture, pesticides, and FMCG. Operating from two manufacturing units in Bari Brahmana, Jammu, Phytochem Remedies commenced manufacturing operations in 2014 with a semi-automatic line and significantly upgraded its capabilities in 2022 by establishing a fully automatic corrugated board plant to enhance efficiency and production capacity.
Dec 18, 2025
Dec 22, 2025
Dec 26, 2025
SME
Closed
38.22 Cr
38.22 Cr
0 Cr
₹98 - ₹98
1200
The net proceeds from the issue are proposed to be utilized for the following main objectives:
Funding capital expenditure for purchasing new equipment and machinery, including a six-color printing machine, a fully automatic paper bag manufacturing machine, and specialized coating lines to enhance production capacity and product quality.
Financing civil construction to expand existing manufacturing facilities at Unit I and Unit II, including building sheds to house the new machinery and support infrastructure for expanded operations.
Repayment or pre-payment, either in full or in part, of certain existing borrowings availed by the company to strengthen the balance sheet and reduce finance costs.
Allocating funds for general corporate purposes, which may include meeting working capital requirements, funding business development initiatives, and covering operational expenses to support overall growth.
17.24
5.68
34.07%
25.29%
34.07%
—
12.25%
23.78%
2.35
Rising consumerism, urbanization, and e-commerce growth have driven demand for packaging across FMCG, pharma, food, and electronics sectors.
Packaging is used across almost all industries including food & beverage, pharmaceuticals, agriculture, textiles, and personal care.
Government policies like 'Make in India' and incentives for MSMEs are boosting domestic manufacturing.
Availability of low-cost skilled labor makes the Indian packaging industry competitive on a global scale.
The industry is highly fragmented with many small, unorganized players using outdated technology, leading to inconsistent quality.
There is a significant dependence on imports for high-quality machinery and certain specialized raw materials.
Investment in research and development is low, resulting in limited innovation and slow adoption of advanced technologies like smart packaging.
The heavy reliance on single-use plastics continues to be a major issue, attracting regulatory scrutiny and environmental backlash.
The boom in e-commerce creates a massive opportunity for protective, lightweight, and branded packaging solutions.
There is a rising consumer and regulatory demand for sustainable options like biodegradable, compostable, and recyclable packaging.
Increasing penetration of packaged goods into tier-2 and rural areas opens up new, untapped markets for growth.
India is emerging as a potential hub for exporting packaging materials to growing markets in Asia, Africa, and the Middle East.
Strict environmental regulations, including bans on certain types of plastics, can disrupt operations and require costly adjustments.
Profit margins are susceptible to the fluctuating costs of essential raw materials like paper, plastic resins, and aluminum.
The domestic market faces significant challenges from cheaper imports, particularly from countries like China and Thailand.
A delay in adopting global technological trends such as Industry 4.0, AI, and IoT can lead to a significant competitive disadvantage.
Phytochem Remedies (India) Limited, incorporated in 2002, is a manufacturer of high-quality corrugated packaging solutions. The company specializes in producing printed boxes, rolls, pads, and sheets, catering to diverse industries such as pharmaceuticals, agriculture, pesticides, and FMCG. Operating from two manufacturing units in Bari Brahmana, Jammu, Phytochem Remedies commenced manufacturing operations in 2014 with a semi-automatic line and significantly upgraded its capabilities in 2022 by establishing a fully automatic corrugated board plant to enhance efficiency and production capacity.
The Phytochem Remedies (India) Ltd. IPO is scheduled to open for subscription on Dec 18, 2025 and close on Dec 22, 2025. Investors can apply for shares during this period through eligible platforms.
The price band for the Phytochem Remedies (India) Ltd. IPO is ₹98 to ₹98. Investors can place bids within this range once the issue opens.
The minimum lot size for the Phytochem Remedies (India) Ltd. IPO is 1200 shares. The minimum investment amount ₹1,17,600.
The total issue size of the Phytochem Remedies (India) Ltd. IPO is approximately ₹38.22. Issue size represents the total value of shares offered to the public.
As per the latest available information, the Phytochem Remedies (India) Ltd. IPO has been subscribed 0.23 times. Subscription levels can change significantly during the offer period.
The Grey Market Premium (GMP) for the Phytochem Remedies (India) Ltd. IPO is not available as of now. GMP reflects unofficial market sentiment and should not be considered a guarantee of listing performance.
The shares of Phytochem Remedies (India) Ltd. are expected to list on stock exchanges on Dec 26, 2025, subject to completion of the allotment process and regulatory approvals.
The net proceeds from the Phytochem Remedies (India) Ltd. IPO are proposed to be used for The net proceeds from the issue are proposed to be utilized for the following main objectives:, Funding capital expenditure for purchasing new equipment and machinery, including a six-color printing machine, a fully automatic paper bag manufacturing machine, and specialized coating lines to enhance production capacity and product quality., Financing civil construction to expand existing manufacturing facilities at Unit I and Unit II, including building sheds to house the new machinery and support infrastructure for expanded operations., Repayment or pre-payment, either in full or in part, of certain existing borrowings availed by the company to strengthen the balance sheet and reduce finance costs., Allocating funds for general corporate purposes, which may include meeting working capital requirements, funding business development initiatives, and covering operational expenses to support overall growth.
Before applying for the Phytochem Remedies (India) Ltd. IPO, investors generally review the company’s business model, financial performance, valuation, industry outlook, and risk factors mentioned in the offer document.
